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Different Consequences of b1 Integrin Deletion in Neonatal and
Adult Mouse Epidermis Reveal a Context-Dependent Role of
Integrins in Regulating Proliferation, Differentiation, and
Intercellular Communication
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There are conﬂicting reports of the consequences of deleting b1 integrins from the epidermis of transgenic mice.
Epidermal thinning with normal differentiation and lack of inﬂammation has been observed; conversely, epidermal
thickening, abnormal differentiation, and dermal ﬁbrosis can occur. b1 integrin deletion results in decreased ep-
idermal proliferation, yet on wounding the proliferative defect is overcome. To distinguish primary from secondary
consequences of b1 integrin loss, we compared epidermal b1 deletion at E14.5 via K5Cre and 4-hydroxy-tamoxifen
induced deletion in adulthood via K14CreER. As reported previously, there was dermo-epidermal splitting, in-
ﬂammation, reduced proliferation, and hair follicle and sebaceous gland loss in 30-d-old K5Cre b1-null mice. These
changes were not observed 30 d after b1 integrin deletion in adult epidermis, however, and there were no changes
in the hair follicle stem cell compartment. Deletion in adult epidermis revealed a previously unreported correlation
between the level of b1 integrins and proliferation in the interfollicular epidermis that was remarkably consistent
with human epidermis. In addition, the number of melanocytes in interfollicular epidermis was greatly increased.
Our results highlight the context-dependent effects of b1 integrin deletion and suggest that inﬂammation may be
responsible for some of the K5Cre b1-null phenotype.
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Extracellular matrix receptors of the integrin family anchor
the epidermis to the underlying basement membrane (Watt,
2002; Danen and Sonnenberg, 2003). The most abundant
epidermal integrins are the collagen receptor, a2b1, and two
laminin receptors, a3b1 and a6b4 (Watt, 2002). In addition to
their role in anchorage, functions for integrins in regulating
exit from the stem cell compartment and the onset of termi-
nal differentiation have been proposed (Watt, 2002), and
aberrant integrin expression is linked to skin inflammation
and cancer (Owens and Watt, 2001, 2003; Watt, 2002; Hob-
bs and Watt, 2003; Owens et al, 2003; Hobbs et al, 2004).
The a6b4 integrin is a component of hemidesmosomes
and is required for epidermal attachment (Danen and Son-
nenberg, 2003). a6b4 deletion in mice or mutation in hu-
mans with junctional epidermolysis bullosa causes the
epidermis to detach from the underlying basement mem-
brane. Overexpression of this integrin correlates with poor
prognosis in human and mouse squamous cell carcinomas
and one mechanism involves disruption of TGF-b respon-
siveness (Owens and Watt, 2003; Owens et al, 2003). But
there is no evidence that a6b4 regulates epidermal differ-
entiation per se (DiPersio et al, 2000).
In contrast to the importance of a6b4 in epidermal an-
chorage, a2b1 is completely dispensable (Chen et al, 2002)
and deletion of a3b1 results only in small epidermal blisters
on the palms and soles of mice (DiPersio et al, 1997). When
all b1 integrins are deleted, via keratin (K) 5 or K14Cre-
mediated recombination, there is detachment of the epi-
dermis from the underlying dermis (Brakebusch et al, 2000;
Raghavan et al, 2000). The phenotype, however, is more
complex to interpret than that of a6b4 deletion. Hair follicles
either fail to form (Raghavan et al, 2000) or form and then
regress (Brakebusch et al, 2000). Mice that die shortly after
birth (K14Cre deletion) have reduced epidermal proliferation
and thinning of the epidermis but differentiation is normal
(Raghavan et al, 2000). In mice that survive for up to 6 wk
after birth (K5Cre deletion) proliferation is also reduced, but
there is epidermal thickening, abnormal differentiation, der-
mal fibrosis, and inflammation (Brakebusch et al, 2000).
Epidermal wound healing in these mice is delayed, but
nevertheless proliferation is increased to the same extent as
in wounded wild-type epidermis (Grose et al, 2002).
The K5 and K14 promoters used to drive transgene ex-
pression are largely faithful to the patterns of expression of
the endogenous keratins and the transgene promoters are
of comparable strength with one another (Byrne et al, 1994;
Abbreviations: Brdu, 5-bromo-20-deoxyuridine; CDP, CCAAT dis-
placement protein; LRC, label retaining cells; 4OHT, 4-hydroxy-
tamoxifen
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Ramirez et al, 1994, 2004; Wang et al, 1997). Nevertheless,
it has been suggested that the different phenotypes of mice
with epidermal deletion of b1 integrins reflect the impact of
more or less efficient Cre-mediated recombination (Ragha-
van et al, 2000). It has also been proposed that skin inflam-
mation is triggered by hair follicle degeneration (Brakebusch
et al, 2000) and that elevated cytokine production in wound-
ed skin may overcome the defect in proliferation (Grose
et al, 2002). In addition, in cultured keratinocytes there can
be compensation for b1 integrin loss by upregulation of av
integrins (Raghavan et al, 2003). As the K5 and K14 pro-
moters are upregulated by E14.5 of gestation (Byrne et al,
1994; Brakebusch et al, 2000; Raghavan et al, 2000) it is
also to be expected that effects of b1 deletion in embryonic
epidermis will influence the postnatal phenotype.
In order to distinguish primary and secondary conse-
quences of b1 deletion, we have compared the K5Cre b1-
null phenotype (Brakebusch et al, 2000) with the phenotype
of mice in which b1 deletion is induced in adulthood via
Tamoxifen activatable K14Cre (K14CreER) (Vasioukhin et al,
1999; Hong et al, 2004). We made use of a recently de-
scribed method for whole-mount labeling (Braun et al,
2003), which facilitates examination of proliferation and dif-
ferentiation in large areas of the epidermis without the need
to prepare conventional histological sections.
Results
Visualization of the consequences of b1 integrin dele-
tion using epidermal whole mounts As previously report-
ed (Brakebusch et al, 2000), mice with K5Cre-mediated
deletion of the b1 integrin subunit could be distinguished at
2 d after birth because their skin was pink, not black (data
not shown). By 5 d the mice were smaller than wild-type
littermates. They did not develop a full coat of hair and by 4
wk they walked with an odd gait as a result of tight and
blistered skin. The mice had to be killed at 4 wk after birth.
It has previously been reported that when the b1 integrin
subunit is deleted from the epidermis via K5Cre there is a
decrease in epidermal proliferation, together with hair loss,
epidermal blistering and dermal fibrosis (Brakebusch et al,
2000). Hematoxylin and eosin (H & E)-stained sections of
back skin showed that the hair follicles were abnormal at 1
wk (Fig 1A, B). By 2 wk the interfollicular epidermis (IFE) was
considerably thickened compared with wild-type (Fig 1C).
At 3 and 4 wk there was an inflammatory infiltrate in the
dermis, marked degeneration of the hair follicles and splits
at the dermal–epidermal junction (Fig 1D, E). All of these
findings are in good agreement with previous observations
(Brakebusch et al, 2000).
We next examined how these changes looked in whole
mounts of tail epidermis. At least 20 K5Cre  floxed b1
mice were examined, with a minimum of five at each time
point. In the wild-type whole mounts there was the char-
acteristic arrangement of the hair follicles in groups of three,
with prominent sebaceous glands (Fig 1F). As described
previously (Braun et al, 2003), there was relatively uniform
expression of b1 integrins (Fig 1F). Proliferating cells, vis-
ualized by Ki67 immunoreactivity, were found throughout
the IFE basal layer and the periphery of the sebaceous
glands (Fig 1F). The permanent portion of the follicles, be-
low the sebaceous glands and above the follicle bulb, is
known as the bulge (Fig 1F). The bulge region was relatively
devoid of proliferating cells, whereas the bulb of anagen
follicles was highly proliferative (Fig 1F).
Antibody staining confirmed the loss of b1 integrins in
whole mounts of tail epidermis from K5Cre b1-null mice (Fig
1G–J). As reported previously (Brakebusch et al, 2000), how-
ever, the deletion was not uniform, and at 1 and 2 wk sig-
nificant b1 immunoreactivity remained in some follicles (Fig
1G, H). By 4 wk the previously reported decrease in prolif-
eration was clear in all regions, but was particularly striking at
the bulb (Fig 1J). From 3 wk onward the sebaceous glands
were either absent or greatly reduced in size (Fig 1I, J).
Figure 1
K5Cre-mediated b1 integrin deletion results in profound changes in epidermal architecture and proliferation. (A–E) Hematoxylin and eosin-
stained sections of the back skin of wild-type (WT) (A) and b1-null (KO) (B–E) mice. Arrows in C, D, E indicate separation of epidermis and dermis.
(F–J) Whole mounts of WT (F) and b1-null (G–J) tail epidermis, labeled with antibodies to b1 integrins (green) or Ki67 (red). IFE, interfollicular
epidermis; HF, hair follicle; SG, sebaceous gland; BG, bulge. Arrowheads in (I) and (J) indicate loss of sebaceous glands. Mice were examined 1
(A, B, G), 2 (C, H), 3 (D, F, I ), and 4 (E, J ) wk after birth. Scale bars: 100 mm (A–E, F–J).
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In normal epidermis, the major b1 integrins are a2b1 and
a3b1, whereas av forms a heterodimer with the b5 subunit
(Watt, 2002). In wild-type epidermis the a2 and av integrin
subunits were detected in the basal layer of the inter-
follicular epidermis (Fig 2A, C). In 4-wk-old K5Cre b1-null
epidermis there was very little detectable a2 integrin (Fig
2B). In contrast, the av subunit was upregulated in the sup-
rabasal layers (Fig 2D), consistent with earlier observations
of suprabasal integrin expression in thickened IFE (Watt,
2002) and with the upregulation of av integrins in some
cultures of b1-null keratinocytes (Raghavan et al, 2003). As
previously reported, deletion of b1 integrins led to abnormal
deposition of type IV collagen (ligand for a2b1) (Fig 2E, F)
and laminin 5 (ligand for a3b1) (Fig 2G, H) in the dermis.
Perturbed IFE differentiation It was previously reported
(Raghavan et al, 2000) that deletion of b1 integrins via
K14Cre-mediated recombination does not alter the pro-
gram of terminal differentiation within the IFE. But the
number of differentiated cell layers is increased in K5Cre b1-
null epidermis (Brakebusch et al, 2000). We re-evaluated the
impact of b1 deletion on IFE differentiation using a combi-
nation of whole-mount labeling and conventional histology
of 30-d-old tail epidermis and a wider range of terminal
differentiation markers than examined previously (Fig 3).
Whole mounts predominantly reveal staining in the ep-
idermal basal layer because the permeabilization conditions
do not allow access of antibodies to all the suprabasal lay-
ers (Jensen et al, 1999; Braun et al, 2003). Thus, when wild-
type epidermis is stained with an antibody to keratin 10
there is scattered staining, reflecting keratin 10-positive
basal cells in the interfollicular epidermis (Fig 3A). Keratin 10
is not expressed in the sebaceous glands and hair follicles
(Fig 3A). Whole-mount labeling of wild-type epidermis re-
veals an area of IFE encircling each hair follicle triplet that is
not labeled with antibodies to keratin 10 (Braun et al, 2003;
Fig 3A). Tail IFE consists of zones of parakeratotic and or-
thokeratotic differentiation (Schweizer et al, 1987) and the
keratin 10-negative regions correspond to the parakeratotic
scale epidermis (see Fig 8A). The keratin 10-negative re-
gions of interfollicular epidermis were not seen in b1-null
epidermis; instead, the entire IFE had scattered keratin 10-
positive basal cells (Fig 3B). Conventional sections revealed
that in the thickened b1-null epidermis there were more
layers of keratin 10-positive cells than in the wild-type (Fig
3C, D). But there was no significant increase in the number
of keratin 10-positive basal cells (Fig 3C, D).
Involucrin, like keratin 10, is normally expressed in the
suprabasal layers of IFE (Fig 3G) and is also expressed in
scattered basal cells that are visualized in whole mounts of
wild-type epidermis (Fig 3E). In whole mounts of K5Cre b1-
null epidermis, staining of involucrin was decreased overall
(Fig 3F). Immunostaining of sections revealed that involucrin
expression was more patchy in b1-null epidermis than in
wild-type: it was reduced overall, but extended to the basal
layer in places (Fig 3H).
Keratin 14 staining of whole mounts revealed an increase
in surface area of the b1-null basal cells in the IFE (Fig 3I, J),
in agreement with the observation that K14Cre b1-null basal
keratinocytes are abnormally flattened (Raghavan et al,
2000). Conventional sections showed increased numbers of
cell layers that were positive for cornifin (Fig 3M, N), loricrin
(Fig 3K, L), and transglutaminase 1 (Fig 3O, P), all of which,
like involucrin, are components of the epidermal cornified
envelope. The transglutaminase staining (Fig 3P) was rem-
iniscent of involucrin (Fig 3H) in being patchy and partially
localized to the basal layer (Fig 3P). Keratin 6 was confined
to the follicles in wild-type mice; however, there was up-
regulation in the IFE of transgenic mice (data not shown).
We conclude that when b1 integrins are deleted from the
epidermis terminal differentiation is disturbed, in contrast to
Figure2
K5Cre-mediated b1 integrin deletion results in perturbed expres-
sion of integrins and basement membrane proteins. Sections of
wild-type (WT) (A, C, E, G) and b1-null (KO) (B, D, F, H) epidermis were
labeled with the antibodies shown and counterstained with DAPI (blue).
Scale bars: 100 mm.
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an earlier report (Raghavan et al, 2000). There are increased
numbers of cell layers expressing keratin 10, cornifin,
loricrin, involucrin, and transglutaminase. The terminal dif-
ferentiation program is not entirely normal because of the
upregulation of keratin 6, the patchy expression of in-
volucrin and transglutaminase 1, and the altered pattern of
keratin 10 expression that is visualized in the whole mounts.
Loss of hair follicles and sebaceous glands It has pre-
viously been reported that the hair follicles degenerate in
K5Cre b1-null skin (Brakebusch et al, 2000), and this was
clear from the whole mounts, as well as conventional sec-
tions (Fig 1). No anagen (growing) follicles were observed
after 2 wk; the follicles were shorter than wild-type and
lacked a discrete bulb (Fig 1I, J). In addition, the sebaceous
glands were largely absent from 2 wk after birth (Fig 1I, J).
CCAAT displacement protein (CDP) is normally expressed in
the bulb of hair follicles and is prominent at anagen (Braun
et al, 2003) (Fig 4A). However, essentially all CDP expres-
sion was lost by day 30 in K5Cre b1-null epidermis (Fig 4B).
Nile Red staining revealed differentiated sebocytes in wild-
type epidermis (Fig 4C). In contrast, there was very little Nile
Red staining in the b1-null epidermis (Fig 4D), consistent
with loss of the sebaceous glands.
Figure 3
K5Cre-mediated b1 integrin deletion results in perturbed interfollicular epidermis (IFE) differentiation. Whole mounts (A, B, E, F, I, J) and
histological sections (C, D, G, H, K, L, M–P) of wild-type (WT) (A, E, I, M, C, G, K, O) and knockout (KO) (B, F, J, N, D, H, L, P) 30-d-old epidermis
were labeled with the antibodies shown. Arrows in (A) demarcate K10 negative, parakeratotic scale IFE encircling a hair follicle triplet. K10,
keratin 10 (green; A–D); K14, keratin 14 (red; C–L; O, P); Inv, involucrin (green; E–H); corn, cornifin (green; M, N); lor, loricrin (green; K, L); or
transglutaminase (green; O, P). Sections in (M) and (N) were counterstained with propidium iodide (PI; red). Scale bars: 200 mm (A, B, E, F, M, N);
50 mm (C, D, G–L, O, P).
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The changes in the hair follicles and sebaceous glands
were not accompanied by any increase in apoptosis, as
detected by TUNEL labeling (Fig 4E, F). In both wild-type
and b1-null epidermis scattered apoptotic keratinocytes
were found at the base of the hair follicles (Fig 4E, F).
To examine the effects of K5Cre-mediated deletion of b1
integrins on the hair follicle stem cell compartment, we used
two protein markers of the bulge (Braun et al, 2003), CD34
(Trempus et al, 2003; Fig 5A), and the a6b4 integrin (Tani
et al, 2000; Fig 5E). In regressing b1-null follicles CD34 was
still expressed, but the CD34-positive zone now extended
to the bottom of the follicles, suggesting that the bulge re-
mained even after the bulb had disappeared (Fig 5B). In
wild-type epidermis the a6b4 integrin is expressed in the
basal layer of the IFE, the periphery of the sebaceous
glands, and along the outer root sheath of the hair follicle,
but is upregulated in the bulge (Fig 5E). Strong staining was
also seen along the remaining outer root sheath of the b1
null follicles (Fig 5F), the same region that was positive for
CD34. Whereas in wild-type epidermis a6b4 was concen-
trated at the basement membrane zone (Fig 5I), in b1-null
epidermis the distribution was more pericellular (Fig 5J).
One characteristic of epidermal stem cells is that they
tend to divide infrequently; as a result they can be visualized
as DNA label retaining cells (LRC) (Bickenbach, 1981; Braun
and Watt, 2004). To generate LRC, neonatal mice are given
repeated injections of 5-bromo-20;-deoxyuridine (BrdU),
which is incorporated into all S phase cells; the cells that
retain the label in adulthood can then be examined in con-
ventional sections or whole mounts (Bickenbach, 1981;
Braun et al, 2003; Braun and Watt, 2004). One day after
labeling, the majority of K14-positive cells were BrdU pos-
itive in both wild-type (Fig 5C) and b1-null (Fig 5D) epidermis.
By 20 d, the majority of LRC in wild-type epidermis were
clustered in the hair follicle bulge, with only a small number
of LRC in the interfollicular epidermis and sebaceous gland
(Fig 5G). The distribution of LRC was markedly different in b1
null epidermis: BrdU-positive cells were found not only in the
bulge but also the bulb of hair follicles, and there were many
LRC in the interfollicular epidermis (Fig 5H).
The most likely explanation for the increased number of
LRC is the reduced proliferation rate in b1 null epidermis
(see Fig 1J). When cells are proliferating more slowly or less
frequently it takes longer for labeled cells to clear the ep-
idermis. In support of this interpretation, the number of
BrdU-positive cells in the suprabasal, differentiating layers
of the interfollicular epidermis was higher in K5Cre b1-null
(Fig 5L) than wild-type (Fig 5K) skin.
We conclude that K5Cre b1-null epidermis fails to main-
tain hair follicles and sebaceous glands. But this is not cor-
related with an increase in apoptosis and the remnants of
the follicle still express CD34 and high levels of a6b4, two
bulge markers. When proliferating cells are labeled with
BrdU it takes longer for the labeled cells to clear the ep-
idermis. The increased number of labeled cells in the inter-
follicular epidermis could reflect cells dividing fewer times
before initiation of terminal differentiation, and the greater
number of cell layers that the labeled cells must transit
before desquamation.
Deletion of b1 integrins in adult epidermis The K5Cre or
K14Cre approach to b1 integrin deletion has some limita-
tions. First, the mice do not survive beyond 5–6 wk (Brake-
busch et al, 2000; Raghavan et al, 2000). Second, the K5
and K14 promoters are expressed from E9.5 onward and
upregulated by E14.5 (Byrne et al, 1994), and so integrin
deletion occurs before birth. Third, there is a strong inflam-
matory infiltrate in the skin of postnatal K5Cre b1-null mice,
which is likely to affect the overlying epidermis (Brakebusch
et al, 2000; Grose et al, 2002). To overcome these problems
we crossed the floxed b1 mice with K14CreER mice. Al-
though CreER is expressed by all cells in which the keratin
14 promoter is active, which are essentially the same pop-
ulation as those expressing K5Cre (Ramirez et al, 2004), Cre
is only activated following topical application of 4-hydroxy-
tamoxifen (4OHT) (Vasioukhin et al, 1999; Hong et al, 2004).
It is thus possible to control the timing and location of b1
integrin deletion.
Figure 4
K5Cre-mediated b1 integrin deletion results in loss of hair follicles
and sebaceous glands without increased apoptosis. Whole mounts
of 30-d-old wild-type (WT) and knockout (KO) tail epidermis were
labeled with anti-CCAAT displacement protein (CDP) (green; A, B); Nile
Red (green; C, D); TUNEL reagent (green; E, F); or propidium iodide (PI;
red; E, F). Brackets show position of sebaceous glands in C, D, and
zone of apoptotic hair follicle cells in (E) and (F). Scale bars: 200 mm (A,
B, E, F); 100 mm (C, D).
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Mice were treated with 4OHT at ages 6–9 wk. The mice
received three treatments, once every 2 d, on the tail. They
were examined 5, 10, 20, or 30 d after the first treatment
and compared with age-matched wild-type littermates that
had also been treated with 4OHT (Fig 6 and data not shown).
At 5 d, wild-type and K14CreER floxed b1 epidermis was
indistinguishable by immunofluorescence labeling for b1 in-
tegrins (Fig 6D, E). Loss of b1 integrin protein first became
obvious at 10 d: patches of reduced expression were noted
in the interfollicular epidermis and periphery of the seba-
ceous gland (Fig 6F). By 20 d the integrin loss was extensive
in the IFE, hair follicles, and sebaceous glands (Fig 6J, K).
In floxed b1 integrin mice a promoterless lacZ reporter
gene has been introduced after the downstream loxP site
(Brakebusch et al, 2000). Therefore, following Cre-mediated
ablation of the b1 integrin gene the lacZ reporter gene is
expressed under the control of the b1 integrin promoter,
providing independent confirmation that b1 gene deletion
has occurred (Brakebusch et al, 2000). Whole-mount labe-
ling of tail epidermis for b-galactosidase confirmed that
gene deletion had occurred (Fig 6I, L), and that while it was
extensive in some areas (Fig 6L), it was patchy in others (Fig
6I), consistent with the b1 integrin immunofluorescence da-
ta (Fig 6F).
In H & E-stained sections the only difference between
wild-type and 4OHT treated K14CreER b1-null tail epider-
mis was an increase in the number of melanocytes, from
day 10 onward (Fig 6C, G, H). The lack of a dermal in-
flammatory infiltrate contrasted with K5Cre b1-null epider-
mis (Fig 1D). Epidermal dendritic cells were visualized by
staining tail whole mounts from wild-type, K5Cre b1-null,
and K14CreER b1-null tail epidermis with DEC-205 antibody
(Fig 6M–O; Hobbs et al, 2004). There were slightly more
dendritic cells in the IFE of K14CreER b1-null epidermis (Fig
6N) than wild-type epidermis (Fig 6M). The number of den-
dritic cells, however, was substantially increased in K5Cre
b1-null epidermis (Fig 6O) compared with either K14CreER
b1-null (Fig 6N) or wild-type (Fig 6M) epidermis.
Whereas in 30-d-old K5Cre b1-null epidermis there was a
marked reduction in proliferation (Fig 1J), there were still
significant numbers of Ki67-positive cells in K14CreER
b1-null epidermis at 30 d (Fig 6K). When the interfollicular
Figure 5
Markers of the hair follicle bulge stem cell compartment are still present following K5Cre-mediated b1 integrin deletion. Whole mounts (A–H)
and sections (I–L) of wild-type (WT; A, C, E, G, I, K) and knockout (KO; B, D, F, H, J, L) tail epidermis were labeled with antibodies to CD34 (green; A,
B), 5-bromo-2’-deoxyuridine (BrdU) (green; C, D, G, H, K, L), keratin 14 (red; C, D, G, H, I–L), a6 integrin (green; E, F, I, J). Samples are from 30-d-old
mice, except in (C) and (D), which are from 13-d-old mice. BrdU-positive cells were evaluated 1 d (C, D) or 20 d (G, H, K, L) following the final
injection of BrdU. Brackets indicate the bulge of hair follicles. Arrows indicate BrdU-positive cells in interfollicular epidermis. Scale bars: 200 mm
(A–D, G, H), 100 mm (E, F, K, L), 50 mm (I, J).
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epidermis was viewed at high magnification (Fig 7) it was
clear that in some areas of K14CreER b1-null epidermis there
was actually an increase in proliferation, as evaluated by
labeling for Ki67 (Fig 7A–D). c-Jun expression was also up-
regulated in the basal layer in a manner that correlated with
the increase in Ki67-positive cells (Fig 7E, F; Mehic et al,
2005). Where there was no detectable b1 integrin there were
very few proliferative or c-Jun-positive cells. In regions where
integrin levels were reduced, but still detectable, however, the
numbers of Ki67- and c-Jun-positive cells were increased.
Effects of adult b1 integrin deletion on interfollicular
epidermis, sebaceous glands, and hair follicles In con-
trast to the consequences of K5Cre-mediated b1 integrin
deletion (Fig 1), there was no thickening of the epidermis
following K14CreER-mediated b1 deletion, nor was there
gross evidence of a dermal inflammatory infiltrate, splitting
at the dermo-epidermal junction, or loss of sebaceous
glands or hair follicles (Fig 6). In addition, there was no ev-
idence for abnormal type IV collagen deposition in the de-
rmis (data not shown). The expression of involucrin (Fig 8C,
D), loricrin (Fig 8E, F) and cornifin (data not shown) was
indistinguishable between wild-type and K14CreER b1-null
epidermis 30 d after initiation of 4OHT treatment. In contrast
to K5Cre b1-null tail epidermis (Fig 3A, B), the regions of
keratin 10-negative parakeratotic epidermis were still
present in K14CreER b1-null epidermis, although their size
was reduced compared with wild-type (Fig 8A, B). The only
strong evidence for perturbed differentiation in the inter-
follicular epidermis was expression of keratin 17 (Fig 8G–J),
a keratin that is normally expressed only in the hair follicle
(McGowan and Coulombe, 1998) (Fig 8G, I). Keratin 17 ex-
pression in the interfollicular epidermis was also observed in
K5Cre b1-null mice (data not shown).
Figure 6
K14CreER-mediated b1 integrin dele-
tion results in minor changes to the
epidermis. Hematoxylin and eosin-stain-
ed sections (A–C, G, H) or whole mounts
(D–F, I–N) of tail epidermis were examined
5 (A, B, D, E), 10 (C, F), 20 (G, J), or 30 (H,
K. M, N) d after the first 4-hydroxy-ta-
moxifen (4OHT) treatment of K14CreER
 floxed b1 mice (KO; B, C, E, F, G, H, J,
K, N) or littermate controls that were het-
erozygous for the floxed b1 allele (WT; A,
D, M). O: K5Cre  floxed b1 mouse tail
epidermis 30 d after birth. (I, L) Whole
mounts of K14CreER  floxed b1 
K14b1 integrin epidermis treated for 28 d
with 4OHT and left untreated for 28 d.
(D–F, J, K) immunolabeling with antibody
to b1 integrins (green) and Ki67 (red).
(I, L) LacZ staining. (M–O) staining with
antibody to dendritic cells. Scale bars:
100 mm (A–H, I–O).
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In contrast to K5Cre b1-null epidermis (Fig 4), there was
no loss of expression of CDP in K14CreER epidermis (Fig
8K, L). The sebaceous glands were reduced in size, as
evaluated by Nile Red staining (Fig 8M, N), but did not show
the dramatic loss seen in K5Cre b1-null epidermis (Fig 4).
Although the hair follicles were maintained following
K14CreER-mediated b1 integrin deletion, there was some
expansion of the outer root sheath and in some hair follicles
the bulbs were thin and elongated (Fig 8H).
Maintenance of the hair follicle stem cell compartment
in K14CreER b1-null epidermis To evaluate the conse-
quences of K14CreER-mediated b1 integrin deletion on the
hair follicle stem cell compartment, we examined expres-
sion of three bulge markers: CD34 (Trempus et al, 2003),
keratin 15 (Lyle et al, 1998), and elevated a6b4 integrin lev-
els (Tani et al, 2000). Thirty days after the first treatment with
4OHTexpression of the a6 integrin subunit (Fig 9A, B), CD34
(data not shown) and keratin 15 (Fig 9C, D) remained ele-
vated in the bulge.
In K5Cre b1-null epidermis it was not possible to use
label retention as a stem cell marker because of the delay
in clearance of label from the epidermis (Fig 5). But in
K14CreER crosses that had not been treated with 4OHT the
number and distribution of LRC was the same as in wild-
type epidermis (Fig 9E and data not shown). Thirty days
after initiation of 4OHT treatment the number of LRC per
follicle was unchanged, even though the epidermis was
lacking b1 integrins (Fig 9E, F).
We conclude that K14CreER-mediated deletion of b1
integrins in adult epidermis results in a much less severe
phenotype than K5Cre (Brakebusch et al, 2000) (Figs 1–5)
or K14Cre (Raghavan et al, 2000)-mediated deletion.
There were no major changes in expression of terminal
differentiation markers in the interfollicular epidermis; the
sebaceous glands and hair follicles were preserved and,
as in the case of K5Cre b1-null epidermis (Fig 5), there
was no evidence for alterations in the hair follicle stem cell
compartment.
Increased number of melanocytes in K14CreER b1-null
epidermis The most striking abnormality of K14CreER b1-
null skin was a large increase in melanocytes in the inter-
follicular epidermis (Fig 6C, G, H). In postnatal wild-type
(Carroll et al, 1997; Nishimura et al, 2002; Fig 10A–C) and
K5Cre b1-null (Brakebusch et al, 2000; Fig 1B–E) skin, me-
lanocytes are largely confined to the hair follicles (data not
shown). By 10 d after the first 4OHT treatment, however, an
increased number of melanocytes were evident in H &
E-stained sections of K14CreER b1-null epidermis (Fig 6C),
and this was even more apparent from 20 d onward (Fig 6G,
H; Fig 10D).
The increase in melanocytes was readily visualized in
whole mounts of tail epidermis 20 or 30 d after the first
4OHT treatment (Fig 10B, E and data not shown). L-DOPA
staining of differentiated melanocytes revealed small num-
bers of scattered cells in the interfollicular epidermis of wild-
type mice, in addition to the cells within the hair follicles (Fig
10B). In contrast, there were numerous L-DOPA-positive
cells in K14CreER b1-null interfollicular epidermis by 20 d
after the first 4OHT treatment (Fig 10E). Nestin is a neural
stem cell marker that is upregulated when dermal papilla
cells are grown in culture (Joannides et al, 2004); in wild-
type epidermis most nestin-positive cells are found at the
hair follicle bulb, corresponding to dermal papilla cells (Fig
10C; Silva-Vargas et al, 2005). Anti-nestin staining revealed
an increase in positive cells along the length of the hair
follicles and in the interfollicular epidermis following 4OHT
induced b1 integrin deletion.
Discussion
By using 4OHT inducible Cre recombinase we have been
able to analyze the consequences of deleting b1 integrins in
adult mouse epidermis. Thirty days after 4OHT treatment
there was no separation of the epidermis from the under-
lying dermis, no evidence for dermal fibrosis or inflamma-
tion, and little perturbation of IFE differentiation. Although in
some areas of the interfollicular epidermis proliferation was
decreased, in other areas it was increased, so that overall
Figure 7
K14CreER-mediated b1 integrin deletion results in regions of in-
creased proliferation in the basal layer of the interfollicular epi-
dermis. Tail epidermis from knockout (KO) or wild-type (WT) mice
treated with 4-hydroxy-tamoxifen (4OHT) for 30 d was labeled for b1
integrins (green) and Ki67 (red in A–D) or c-Jun (red in E, F). Scale bars:
50 mm (A–D), 100 mm (E, F).
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there was no major reduction in proliferation. Although the
morphology of the hair follicles and sebaceous glands was
slightly abnormal they did not undergo complete regression.
Thus, b1 integrin deletion in adult epidermis has a much less
severe phenotype than deletion during embryonic gestation
via K5Cre or K14Cre (Brakebusch et al, 2000; Raghavan
et al, 2000).
Although different promoters were used to express Cre
and CreER, it is unlikely that this is the cause of the
phenotypic differences in b1-null epidermis. Keratins 5 and
14 are partners that are co-expressed in human and mouse
epidermis (Byrne et al, 1994). The promoters we used are
faithful to the patterns of expression of the endogenous
keratins in epidermis, and are of approximately equivalent
strength (Byrne et al, 1994; Ramirez et al, 1994, 2004; Wang
et al, 1997). Furthermore, the adult deletion phenotype is
much milder than the phenotype generated by deletion
during embryonic gestation, whether via K5Cre or K14Cre
(Brakebusch et al, 2000; Raghavan et al, 2000).
Our results show that loss of b1 integrins per se does not
result in greatly reduced proliferation or trigger massive
inflammation. Rather, the data suggest that the severe phe-
notypes are a consequence of a failure of anchorage, in part
because a mature basement membrane is not elaborated
(Brakebusch et al, 2000; Raghavan et al, 2000). In contrast
to the abnormal basement membrane deposition seen in
K5Cre b1-null skin, immunostaining suggested that the
basement membrane was grossly normal 30 d following b1
deletion via K14CreER.
The explanation for the regression of hair follicles and
sebaceous glands in K5Cre b1-null epidermis is likely to be
the reduction in proliferation in the hair follicle bulb and at
the periphery of the sebaceous glands. It has previously
been suggested that the inflammation in K5Cre b1-null skin
is triggered by the regression of the hair follicles (Brake-
busch et al, 2000). In support of this, the hair follicles did not
regress by 30 d after initiation of 4OHT treatment in
K14CreER b1-null epidermis and there was no evidence of
a dermal inflammatory infiltrate.
One surprising finding was the very long half-life of
b1 integrins in vivo. The half-life of integrins on the surface
of cultured human keratinocytes is about 12 h (Hotchin
Figure 8
K14CreER-mediated b1 integrin
deletion does not result in major
changes in epidermal terminal
differentiation. Sections (A–F) and
whole mounts (G–N) of tail epider-
mis from wild-type (WT; A, C, E, G,
I, K, M) and knockout (KO; B,
D, F, H, J, L, N) mice were labeled
with antibodies to keratin 14 (red;
C–F), keratin 10 (green; A, B), in-
volucrin (green; C, D), loricrin
(green; E, F), keratin 17 (G–J), CCAAT
displacement protein (CDP) (K, L),
and Nile Red (M, N). Arrows in (A)
and (B) show K10-negative scale in-
terfollicular epidermis (IFE). Bracket
in H shows expansion of outer root
sheath; arrow in H shows thinning
of the bulb. Scale bars: 100 mm
(A–F), 200 mm (I–N).
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and Watt, 1992), yet there was only significant loss of b1
integrins by 10 d after Cre activation in mouse epidermis.
The lag was not due to inefficiency of 4OHT penetration
because in other models of K14 transgene induction by
4OHT a phenotype is evident within 1 d (Arnold and Watt,
2001; Lo Celso et al, 2004). Cre is activated within 24 h of
the final 4OHT treatment, when evaluated by crossing
K14CreER mice with mice expressing a floxed b-gala-
ctosidase transgene (Vasioukhin et al, 1999; unpublished
observations).
Several abnormalities in IFE differentiation were ob-
served in K5Cre b1-null epidermis, including an increased
number of differentiated cell layers, delayed clearance of
BrdU labeled cells, premature and patchy expression of in-
volucrin and transglutaminase 1, induction of keratin 17,
and increased numbers of loricrin- and cornifin-positive cell
layers. These are consistent with a previous report that dif-
ferentiation was disturbed (Brakebusch et al, 2000). In
K14CreER b1-null epidermis, however, the only alteration
was induction of keratin 17. This, together with the normal
IFE differentiation of K14Cre b1-null mice that die at birth
(Raghavan et al, 2000), would tend to suggest that it is not
loss of b1 integrins per se that affects differentiation, but
secondary effects, such as dermal fibrosis and upregulated
expression of cytokines (Grose et al, 2002).
One unexpected finding was that in K5Cre b1-null tail
epidermis the K10-negative regions, which correspond to
parakeratotic scale IFE (Schweizer et al, 1987), were lost. In
Figure 9
The hair follicle bulge is maintained
following K14CreER-mediated b1 inte-
grin deletion. Whole mounts of tail epi-
dermis from wild-type (WT; A, C, E) and
knock out (KO; B, D, F) mice were labeled
with antibodies to a6 integrin (A, B), ker-
atin 15 (C, D), keratin 14 (red in E, F), or
BrdU (to detect LRC; green in E, F).
Brackets show position of the bulge. As-
terisks in C, D show non-specific staining
of sebaceous glands. Scale bars: 200 mm
(A–F).
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K14CreER b1-null tail epidermis the K10-negative regions
persisted but were reduced in size. This suggests that the
change in K10 expression may indeed be a direct conse-
quence of b1 integrin deletion. Considerable attention is
currently focused on lineage selection by the epidermal
stem cell compartment (see, e.g., Silva-Vargas et al, 2005).
Tail epidermis provides an excellent model to examine the
factors that regulate the choice between parakeratotic and
orthokeratotic IFE differentiation.
It has been concluded that the b1 integrins play no role in
regulating epidermal terminal differentiation (Raghavan et al,
2000). Nevertheless, there is strong evidence that b1 inte-
grin ligation or mutation can negatively regulate terminal
differentiation of human keratinocytes in culture (Levy et al,
2000; Watt, 2002; Evans et al, 2003). Human epidermal
stem cells in culture and in vivo express higher levels of
b1 integrins than transit amplifying cells and reduced
b1 expression or function is sufficient to trigger exit from
the stem cell compartment in culture (Jones and Watt, 1993;
Jones et al, 1995; Zhu et al, 1999). The conflicting results
can be reconciled by concluding that it is anchorage
rather than integrin expression per se that is important be-
cause when b1 integrins are deleted from mouse keratin-
ocytes in culture differentiation is indeed stimulated (Grose
et al, 2002).
In K5Cre b1-null and K14CreER b1-null epidermis there
was no evidence for loss of the bulge stem cell compart-
ment. Expression of CD34 and keratin 15 was maintained,
as was high expression of the a6b4 integrin. In K14CreER
b1-null mice it was possible to visualize LRC and there was
no evidence that this subpopulation of bulge stem cells was
depleted either. These observations fit with the conclusion
that the bulge compartment is highly quiescent (Braun et al,
2003; Tumbar et al, 2004). The regression of the hair follicles
and sebaceous glands in K5Cre b1-null epidermis is likely to
be because of a failure of proliferation, rather than a positive
effect on lineage selection (Arnold and Watt, 2001; Lo Celso
et al, 2004).
In the basal layer of human IFE there are clusters of cells
that express high levels of b1 integrins and these clusters
are relatively depleted of actively cycling cells, consistent
with the hypothesis that transit amplifying cells express
lower levels of b1 integrins (Jones et al, 1995; Jensen et al,
1999). Such heterogeneity in b1 integrin expression and
location of proliferating cells has not been found in mouse
IFE (Braun et al, 2003). It is thus intriguing that in K14CreER
b1-null IFE the regions that lacked detectable b1 integrins
were depleted of proliferating cells, whereas the regions
with reduced, but detectable, b1 integrins had higher pro-
liferation than wild-type IFE. Differences in b1 integrin levels
could directly affect keratinocyte proliferation, for example
by signaling through Erk MAPK (Zhu et al, 1999) and c-Jun
(Mehic et al, 2005). In addition, integrin expression levels
can affect epidermal cytokine production (Hobbs and Watt,
2003; Edelson et al, 2004; Hobbs et al, 2004).
Whereas in most respects the phenotype of K14CreER
b1-null epidermis was more similar to wild-type than to
K5Cre b1-null epidermis, one striking exception was in the
melanocyte population. In wild-type and K5Cre b1-null post-
natal epidermis, melanocytes were primarily concentrated in
the hair follicles. From 10 d after initiation of 4OHT treatment
to delete b1 integrins from K14CreER epidermis, however,
there was a marked increase in IFE melanocytes. Me-
lanocyte recruitment to the IFE could depend on increased
expression of secreted factors, such as Kit ligand (Nishimura
et al, 2002). In addition, cell–cell and cell–extracellular matrix
interactions regulate melanocyte behavior (Li et al, 2004) and
b1 integrin loss from keratinocytes could potentially disturb
these. It will be interesting to examine the mechanisms by
which b1 integrin deletion in the epidermis leads to an in-
crease in melanocytes in the interfollicular epidermis.
Materials and Methods
Transgenic mice The generation of mice carrying a floxed b1
integrin gene was described previously (Potocnik et al, 2000).
Figure 10
K14CreER-mediated b1 integrin deletion re-
sults in an increase in melanocytes. Sections
(A, D) and whole mounts (B, C, E, F) of tail ep-
idermis from wild-type (WT; A–C) and knock out
(KO; D–F) mice were labeled with hematoxylin
and eosin (A, D), L-DOPA (B, E), antibodies to
keratin 14 (blue in C, F), or nestin (pink in C, F).
Arrows in B show melanocytes in interfollicular
epidermis. Arrow in C shows nestin-positive cells
in dermal papilla. In F, nestin-positive cells in hair
follicles (arrows) and interfollicular epidermis
(arrowheads) are indicated. Scale bars: 200 mm
(B, E), 100 mm (C, F), 50 mm (A, D).
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Transgenic mice expressing the Cre recombinase under the control
of the keratin 5 promoter (K5Cre; C57Bl6 background; Brakebusch
et al, 2000; Grose et al, 2002) or expressing a CreER fusion protein
under the control of the keratin 14 promoter (K14CreER; FVB/n
background; Vasioukhin et al, 1999; Hong et al, 2004) were mated
with floxed b1 integrin mice (C57Bl6 background). Male K5Cre
mice were always used to breed with the floxed b1 integrin mice;
both male and female K14CreER mice were used for crosses. LacZ
staining was performed on tails from triple transgenics:
K14CreER  floxed b1 x K14b1 (wild-type or T188I mutant; FVB/
n) integrin epidermis. All work involving mice was carried out under
the terms of a UK Home Office licence.
The CreER transgene was activated by topical application of
4OHT (Sigma-Aldrich, Gillingham, UK). Four milligrams of 4OHT
dissolved in 0.4 mL acetone was applied to the entire tail once
every 2 d for a total of three treatments. To generate label-retaining
cells, 10-d-old mice were injected with 50 mg per kg body weight
BrdU (20 mL of 12.5 mg per mL BrdU) every 12 h for a total of four
injections (Bickenbach, 1981; Braun et al, 2003).
Antibodies Rat monoclonal antibodies were used to detect BrdU
(Oxford Biotechnology, Oxford, UK), CD34 (RAM34; BD Pharmin-
gen, San Jose, California), a6 integrin (Serotec, Kidlington, UK), b1
integrin (MB 1.2, kindly provided by B. Chan; Von Ballestrem
et al, 1996), and DEC-205 antigen (kind gift of C. Reis e Sousa;
Kraal et al, 1986). Rabbit antisera were used to detect a2 integrin
(DH6, raised against the cytoplasmic domain peptide NH2-
CKYEKMTKNPDEIDETTELSS-COOH), av integrin (Chemicon,
Temecula, California), laminin 5 (kind gift of P. Marinkovich), ker-
atin 6 (Covance, Princeton, New Jersey), keratin 10 (Covance),
keratin 14 (Covance), keratin 17 (kind gift of P. Coulombe; McGo-
wan and Coulombe, 1998), nestin (nestin 130; kind gift of R.
McKay; Marvin et al, 1998), involucrin (Li et al, 2000), loricrin (DH11;
Janes et al, 2004), cornifin (kind gift of A. Jetten; Fujimoto et al,
1997), c-Jun (H-79; Santa Cruz, Santa Cruz, California), Ki67
(Novocastra, Newcastle upon Tyne, UK), and CDP (kindly provided
by M. Busslinger; Ellis et al, 2001). Mouse monoclonal antibodies
were used to detect keratin 15 (LHK15; kindly provided by I. Leigh;
Waseem et al, 1999), transglutaminase 1 (B.C1; kind gift of R. Rice;
Thacher and Rice, 1985), and c-kit (01902-D; BD Pharmingen).
Goat anti-type IV collagen was purchased from Chemicon.
Secondary antibodies were conjugated to AlexaFluor 488 or
AlexaFluor 594 (Molecular Probes, Eugene, Oregon).
Preparation and immunolabeling of epidermal whole
mounts The method to prepare whole mounts of mouse tail ep-
idermis has been described previously (Braun et al, 2003). Intact
sheets of epidermis were fixed in 4% formal saline (Sigma-Aldrich)
for 2 h at room temperature. Epidermal sheets were blocked
and permeabilized by incubation in PB Buffer for 30 min
(Braun et al, 2003). PB buffer consists of 0.5% skim milk powder,
0.25% fish skin gelatin (Sigma-Aldrich), and 0.5% Triton X-100
in TBS (0.9% NaCl, 20 mM HEPES, pH 7.2). Whole mounts
were incubated overnight at room temperature in antibodies
diluted in PB buffer, then washed for at least 4 h in several
changes of PBS containing 0.2% Tween 20. When antibody labe-
ling was complete, whole mounts were rinsed in distilled water and
mounted in Mowiol containing 0.5% 1,4-Diazabicyclo[2.2.2]octane
(Sigma-Aldrich).
To detect BrdU-labeled cells, whole mounts were incubated for
20–30 min in 2M HCl at 371C prior to incubation with the anti-BrdU
antibody. Apoptotic cells were detected with the DeadEndt
Fluorometric TUNEL System (Promega, Southampton, UK). To
stain lipids accumulated in sebocytes, whole mounts were incu-
bated in Nile Red (0.1 mg per mL in PBS; Sigma-Aldrich) for 30 min
at room temperature. To visualize melanocytes, epidermal sheets
were incubated with 0.2% L-DOPA (Acros Organics, Geel, Belgium)
for 3–16 h at 37oC in the dark (Silva-Vargas et al, 2005). LacZ
staining of epidermal whole mounts was performed as described
previously (Silva-Vargas et al, 2005).
Images were acquired using a Zeiss 510 confocal microscope.
All the whole-mount immunofluorescence images shown are z
stacks. Approximately 40 optical sections of each epidermal sheet
were captured with a typical increment of 1–3 mm, scanning from
the dermal side towards the epidermal surface. Zeiss 10/NA 0.45,
Zeiss 20/NA 0.75, and Zeiss 40/NA 1.2 objectives were used. The
images of whole mounts stained for L-DOPA are single slice con-
focal images.
Histological analysis and immunolabeling of tissue sec-
tions Sections of back skin were harvested and either fixed over-
night in 10% neutral-buffered formalin or frozen, unfixed, in OCT
compound (Miles, Elkart, Indiana) on a frozen isopentane surface
(cooled with liquid nitrogen). Formalin-fixed tissue was transferred
to 70% ethanol, embedded in paraffin and sectioned at 5 mm.
Paraffin and frozen skin sections were stained with H & E, and then
examined and photographed using a conventional microscope. All
sections shown are of paraffin embedded tissue, with the excep-
tion of the transglutaminase labeling, which was performed on
frozen sections.
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